Dynavax Receives Complete Response Letter from U.S. FDA for Biologics License Application for HEPLISAV-B Biotech Investing
Thermo Fisher Scientific Submits Premarket Approval Application to FDA for Next-Generation Sequencing-Based Oncology Test Biotech Investing
Pulse Biosciences Announces New Data That Reinforce Potential Immuno-Oncology Benefits of Nano-Pulse Stimulation Technology Biotech Investing
